DANIEL G. WELCH - 02 Feb 2023 Form 3 Insider Report for Structure Therapeutics Inc. (GPCR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	GPCR	Series B Preferred Shares							02 Feb 2023	Ordinary Shares	123,508		By spouse	F1
holding	GPCR	Stock option (right to buy)							02 Feb 2023	Ordinary Shares	1,179,122	$2.60	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	All outstanding Preferred Shares will automatically convert into Ordinary Shares immediately upon the closing of Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date.
F2	1/3rd of the shares shall vest one year after January 5, 2022 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 24 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.